According to YH Research, the global market for Viral and Non Viral Vector Manufacturing should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Viral and Non Viral Vector Manufacturing market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Viral and Non Viral Vector Manufacturing market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Viral Vector segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Gene Therapy has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Viral and Non Viral Vector Manufacturing include Boehringer Ingelheim, Catalent, Fujifilm Holdings Corporation, Danaher Corporation, Rescript Biotech Corporation, Lonza Group Ag, Merck Kagan, Oxford Biomedical Plc and Sartorius Ag, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Viral and Non Viral Vector Manufacturing. Report Highlights:
(1) Global Viral and Non Viral Vector Manufacturing market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Viral and Non Viral Vector Manufacturing market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Viral and Non Viral Vector Manufacturing market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Viral and Non Viral Vector Manufacturing segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Viral and Non Viral Vector Manufacturing segment by type and by application and regional segment by type and by application.
(6) Viral and Non Viral Vector Manufacturing industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Viral Vector
Non-viral Vector
Market segment by application, can be divided into
Gene Therapy
Vaccinology
Cell Therapy
Others
Market segment by players, this report covers
Boehringer Ingelheim
Catalent
Fujifilm Holdings Corporation
Danaher Corporation
Rescript Biotech Corporation
Lonza Group Ag
Merck Kagan
Oxford Biomedical Plc
Sartorius Ag
Takara Bio
Thermo Fisher Scientific
Wuxi Optec
Acuities Therapeutic
Evonik Industries Ag
Exiled
Entos Pharmaceuticals
Genevant Sciences Gmbh
T&T Scientific Corporation
Moderna
Curevac Nv
1 Market Overview
1.1 Product Overview and Scope of Viral and Non Viral Vector Manufacturing
1.2 Global Viral and Non Viral Vector Manufacturing Market Size and Forecast
1.3 China Viral and Non Viral Vector Manufacturing Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Viral and Non Viral Vector Manufacturing Share in Global Market, 2018-2029
1.4.2 Viral and Non Viral Vector Manufacturing Market Size: China VS Global, 2018-2029
1.5 Viral and Non Viral Vector Manufacturing Market Dynamics
1.5.1 Viral and Non Viral Vector Manufacturing Market Drivers
1.5.2 Viral and Non Viral Vector Manufacturing Market Restraints
1.5.3 Viral and Non Viral Vector Manufacturing Industry Trends
1.5.4 Viral and Non Viral Vector Manufacturing Industry Policy
2 Global Competitive Situation by Company
2.1 Global Viral and Non Viral Vector Manufacturing Revenue by Company (2018-2023)
2.2 Global Viral and Non Viral Vector Manufacturing Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Viral and Non Viral Vector Manufacturing Concentration Ratio
2.4 Global Viral and Non Viral Vector Manufacturing Mergers & Acquisitions, Expansion Plans
2.5 Global Viral and Non Viral Vector Manufacturing Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Viral and Non Viral Vector Manufacturing Revenue by Company (2018-2023)
3.2 China Viral and Non Viral Vector Manufacturing Viral and Non Viral Vector Manufacturing Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Viral and Non Viral Vector Manufacturing, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Viral and Non Viral Vector Manufacturing Industry Chain
4.2 Viral and Non Viral Vector Manufacturing Upstream Analysis
4.3 Viral and Non Viral Vector Manufacturing Midstream Analysis
4.4 Viral and Non Viral Vector Manufacturing Downstream Analysis
5 Sights by Type
5.1 Viral and Non Viral Vector Manufacturing Classification
5.1.1 Viral Vector
5.1.2 Non-viral Vector
5.2 By Type, Global Viral and Non Viral Vector Manufacturing Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Viral and Non Viral Vector Manufacturing Revenue, 2018-2029
6 Sights by Application
6.1 Viral and Non Viral Vector Manufacturing Segment by Application
6.1.1 Gene Therapy
6.1.2 Vaccinology
6.1.3 Cell Therapy
6.1.4 Others
6.2 By Application, Global Viral and Non Viral Vector Manufacturing Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Viral and Non Viral Vector Manufacturing Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Viral and Non Viral Vector Manufacturing Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Viral and Non Viral Vector Manufacturing Market Size, 2018-2029
7.3 North America
7.3.1 North America Viral and Non Viral Vector Manufacturing Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Viral and Non Viral Vector Manufacturing Market Size Market Share
7.4 Europe
7.4.1 Europe Viral and Non Viral Vector Manufacturing Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Viral and Non Viral Vector Manufacturing Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Viral and Non Viral Vector Manufacturing Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Viral and Non Viral Vector Manufacturing Market Size Market Share
7.6 South America
7.6.1 South America Viral and Non Viral Vector Manufacturing Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Viral and Non Viral Vector Manufacturing Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Viral and Non Viral Vector Manufacturing Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Viral and Non Viral Vector Manufacturing Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Viral and Non Viral Vector Manufacturing Market Size, 2018-2029
8.3.2 By Company, U.S. Viral and Non Viral Vector Manufacturing Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Viral and Non Viral Vector Manufacturing Market Size, 2018-2029
8.4.2 By Company, Europe Viral and Non Viral Vector Manufacturing Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Viral and Non Viral Vector Manufacturing Market Size, 2018-2029
8.5.2 By Company, China Viral and Non Viral Vector Manufacturing Revenue Market Share, 2018-2023
8.5.3 By Type, China Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Viral and Non Viral Vector Manufacturing Market Size, 2018-2029
8.6.2 By Company, Japan Viral and Non Viral Vector Manufacturing Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Viral and Non Viral Vector Manufacturing Market Size, 2018-2029
8.7.2 By Company, South Korea Viral and Non Viral Vector Manufacturing Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Viral and Non Viral Vector Manufacturing Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Viral and Non Viral Vector Manufacturing Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Viral and Non Viral Vector Manufacturing Market Size, 2018-2029
8.9.2 By Company, India Viral and Non Viral Vector Manufacturing Revenue Market Share, 2018-2023
8.9.3 By Type, India Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Viral and Non Viral Vector Manufacturing Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Viral and Non Viral Vector Manufacturing Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Boehringer Ingelheim
9.1.1 Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position
9.1.2 Boehringer Ingelheim Company Profile and Main Business
9.1.3 Boehringer Ingelheim Viral and Non Viral Vector Manufacturing Models, Specifications and Application
9.1.4 Boehringer Ingelheim Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
9.1.5 Boehringer Ingelheim Recent Developments
9.2 Catalent
9.2.1 Catalent Company Information, Head Office, Market Area and Industry Position
9.2.2 Catalent Company Profile and Main Business
9.2.3 Catalent Viral and Non Viral Vector Manufacturing Models, Specifications and Application
9.2.4 Catalent Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
9.2.5 Catalent Recent Developments
9.3 Fujifilm Holdings Corporation
9.3.1 Fujifilm Holdings Corporation Company Information, Head Office, Market Area and Industry Position
9.3.2 Fujifilm Holdings Corporation Company Profile and Main Business
9.3.3 Fujifilm Holdings Corporation Viral and Non Viral Vector Manufacturing Models, Specifications and Application
9.3.4 Fujifilm Holdings Corporation Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
9.3.5 Fujifilm Holdings Corporation Recent Developments
9.4 Danaher Corporation
9.4.1 Danaher Corporation Company Information, Head Office, Market Area and Industry Position
9.4.2 Danaher Corporation Company Profile and Main Business
9.4.3 Danaher Corporation Viral and Non Viral Vector Manufacturing Models, Specifications and Application
9.4.4 Danaher Corporation Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
9.4.5 Danaher Corporation Recent Developments
9.5 Rescript Biotech Corporation
9.5.1 Rescript Biotech Corporation Company Information, Head Office, Market Area and Industry Position
9.5.2 Rescript Biotech Corporation Company Profile and Main Business
9.5.3 Rescript Biotech Corporation Viral and Non Viral Vector Manufacturing Models, Specifications and Application
9.5.4 Rescript Biotech Corporation Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
9.5.5 Rescript Biotech Corporation Recent Developments
9.6 Lonza Group Ag
9.6.1 Lonza Group Ag Company Information, Head Office, Market Area and Industry Position
9.6.2 Lonza Group Ag Company Profile and Main Business
9.6.3 Lonza Group Ag Viral and Non Viral Vector Manufacturing Models, Specifications and Application
9.6.4 Lonza Group Ag Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
9.6.5 Lonza Group Ag Recent Developments
9.7 Merck Kagan
9.7.1 Merck Kagan Company Information, Head Office, Market Area and Industry Position
9.7.2 Merck Kagan Company Profile and Main Business
9.7.3 Merck Kagan Viral and Non Viral Vector Manufacturing Models, Specifications and Application
9.7.4 Merck Kagan Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
9.7.5 Merck Kagan Recent Developments
9.8 Oxford Biomedical Plc
9.8.1 Oxford Biomedical Plc Company Information, Head Office, Market Area and Industry Position
9.8.2 Oxford Biomedical Plc Company Profile and Main Business
9.8.3 Oxford Biomedical Plc Viral and Non Viral Vector Manufacturing Models, Specifications and Application
9.8.4 Oxford Biomedical Plc Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
9.8.5 Oxford Biomedical Plc Recent Developments
9.9 Sartorius Ag
9.9.1 Sartorius Ag Company Information, Head Office, Market Area and Industry Position
9.9.2 Sartorius Ag Company Profile and Main Business
9.9.3 Sartorius Ag Viral and Non Viral Vector Manufacturing Models, Specifications and Application
9.9.4 Sartorius Ag Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
9.9.5 Sartorius Ag Recent Developments
9.10 Takara Bio
9.10.1 Takara Bio Company Information, Head Office, Market Area and Industry Position
9.10.2 Takara Bio Company Profile and Main Business
9.10.3 Takara Bio Viral and Non Viral Vector Manufacturing Models, Specifications and Application
9.10.4 Takara Bio Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
9.10.5 Takara Bio Recent Developments
9.11 Thermo Fisher Scientific
9.11.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
9.11.2 Thermo Fisher Scientific Company Profile and Main Business
9.11.3 Thermo Fisher Scientific Viral and Non Viral Vector Manufacturing Models, Specifications and Application
9.11.4 Thermo Fisher Scientific Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
9.11.5 Thermo Fisher Scientific Recent Developments
9.12 Wuxi Optec
9.12.1 Wuxi Optec Company Information, Head Office, Market Area and Industry Position
9.12.2 Wuxi Optec Company Profile and Main Business
9.12.3 Wuxi Optec Viral and Non Viral Vector Manufacturing Models, Specifications and Application
9.12.4 Wuxi Optec Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
9.12.5 Wuxi Optec Recent Developments
9.13 Acuities Therapeutic
9.13.1 Acuities Therapeutic Company Information, Head Office, Market Area and Industry Position
9.13.2 Acuities Therapeutic Company Profile and Main Business
9.13.3 Acuities Therapeutic Viral and Non Viral Vector Manufacturing Models, Specifications and Application
9.13.4 Acuities Therapeutic Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
9.13.5 Acuities Therapeutic Recent Developments
9.14 Evonik Industries Ag
9.14.1 Evonik Industries Ag Company Information, Head Office, Market Area and Industry Position
9.14.2 Evonik Industries Ag Company Profile and Main Business
9.14.3 Evonik Industries Ag Viral and Non Viral Vector Manufacturing Models, Specifications and Application
9.14.4 Evonik Industries Ag Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
9.14.5 Evonik Industries Ag Recent Developments
9.15 Exiled
9.15.1 Exiled Company Information, Head Office, Market Area and Industry Position
9.15.2 Exiled Company Profile and Main Business
9.15.3 Exiled Viral and Non Viral Vector Manufacturing Models, Specifications and Application
9.15.4 Exiled Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
9.15.5 Exiled Recent Developments
9.16 Entos Pharmaceuticals
9.16.1 Entos Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.16.2 Entos Pharmaceuticals Company Profile and Main Business
9.16.3 Entos Pharmaceuticals Viral and Non Viral Vector Manufacturing Models, Specifications and Application
9.16.4 Entos Pharmaceuticals Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
9.16.5 Entos Pharmaceuticals Recent Developments
9.17 Genevant Sciences Gmbh
9.17.1 Genevant Sciences Gmbh Company Information, Head Office, Market Area and Industry Position
9.17.2 Genevant Sciences Gmbh Company Profile and Main Business
9.17.3 Genevant Sciences Gmbh Viral and Non Viral Vector Manufacturing Models, Specifications and Application
9.17.4 Genevant Sciences Gmbh Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
9.17.5 Genevant Sciences Gmbh Recent Developments
9.18 T&T Scientific Corporation
9.18.1 T&T Scientific Corporation Company Information, Head Office, Market Area and Industry Position
9.18.2 T&T Scientific Corporation Company Profile and Main Business
9.18.3 T&T Scientific Corporation Viral and Non Viral Vector Manufacturing Models, Specifications and Application
9.18.4 T&T Scientific Corporation Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
9.18.5 T&T Scientific Corporation Recent Developments
9.19 Moderna
9.19.1 Moderna Company Information, Head Office, Market Area and Industry Position
9.19.2 Moderna Company Profile and Main Business
9.19.3 Moderna Viral and Non Viral Vector Manufacturing Models, Specifications and Application
9.19.4 Moderna Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
9.19.5 Moderna Recent Developments
9.20 Curevac Nv
9.20.1 Curevac Nv Company Information, Head Office, Market Area and Industry Position
9.20.2 Curevac Nv Company Profile and Main Business
9.20.3 Curevac Nv Viral and Non Viral Vector Manufacturing Models, Specifications and Application
9.20.4 Curevac Nv Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
9.20.5 Curevac Nv Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables and Figures
Table 1. Viral and Non Viral Vector Manufacturing Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Viral and Non Viral Vector Manufacturing Market Restraints
Table 3. Viral and Non Viral Vector Manufacturing Market Trends
Table 4. Viral and Non Viral Vector Manufacturing Industry Policy
Table 5. Global Viral and Non Viral Vector Manufacturing Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Viral and Non Viral Vector Manufacturing Revenue Market Share by Company (2018-2023)
Table 7. Global Viral and Non Viral Vector Manufacturing Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Viral and Non Viral Vector Manufacturing Mergers & Acquisitions, Expansion Plans
Table 9. Global Viral and Non Viral Vector Manufacturing Manufacturers Product Type
Table 10. China Viral and Non Viral Vector Manufacturing Revenue by Company (2018-2023) & (US$ million)
Table 11. China Viral and Non Viral Vector Manufacturing Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Viral and Non Viral Vector Manufacturing Upstream (Raw Materials)
Table 13. Global Viral and Non Viral Vector Manufacturing Typical Customers
Table 14. Viral and Non Viral Vector Manufacturing Typical Distributors
Table 15. By Type, Global Viral and Non Viral Vector Manufacturing Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Viral and Non Viral Vector Manufacturing Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Viral and Non Viral Vector Manufacturing Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Viral and Non Viral Vector Manufacturing Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Viral and Non Viral Vector Manufacturing Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Viral and Non Viral Vector Manufacturing Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Viral and Non Viral Vector Manufacturing Revenue Market Share, 2018-2029
Table 22. Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position
Table 23. Boehringer Ingelheim Company Profile and Main Business
Table 24. Boehringer Ingelheim Viral and Non Viral Vector Manufacturing Models, Specifications and Application
Table 25. Boehringer Ingelheim Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
Table 26. Boehringer Ingelheim Recent Developments
Table 27. Catalent Company Information, Head Office, Market Area and Industry Position
Table 28. Catalent Company Profile and Main Business
Table 29. Catalent Viral and Non Viral Vector Manufacturing Models, Specifications and Application
Table 30. Catalent Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
Table 31. Catalent Recent Developments
Table 32. Fujifilm Holdings Corporation Company Information, Head Office, Market Area and Industry Position
Table 33. Fujifilm Holdings Corporation Company Profile and Main Business
Table 34. Fujifilm Holdings Corporation Viral and Non Viral Vector Manufacturing Models, Specifications and Application
Table 35. Fujifilm Holdings Corporation Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
Table 36. Fujifilm Holdings Corporation Recent Developments
Table 37. Danaher Corporation Company Information, Head Office, Market Area and Industry Position
Table 38. Danaher Corporation Company Profile and Main Business
Table 39. Danaher Corporation Viral and Non Viral Vector Manufacturing Models, Specifications and Application
Table 40. Danaher Corporation Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
Table 41. Danaher Corporation Recent Developments
Table 42. Rescript Biotech Corporation Company Information, Head Office, Market Area and Industry Position
Table 43. Rescript Biotech Corporation Company Profile and Main Business
Table 44. Rescript Biotech Corporation Viral and Non Viral Vector Manufacturing Models, Specifications and Application
Table 45. Rescript Biotech Corporation Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
Table 46. Rescript Biotech Corporation Recent Developments
Table 47. Lonza Group Ag Company Information, Head Office, Market Area and Industry Position
Table 48. Lonza Group Ag Company Profile and Main Business
Table 49. Lonza Group Ag Viral and Non Viral Vector Manufacturing Models, Specifications and Application
Table 50. Lonza Group Ag Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
Table 51. Lonza Group Ag Recent Developments
Table 52. Merck Kagan Company Information, Head Office, Market Area and Industry Position
Table 53. Merck Kagan Company Profile and Main Business
Table 54. Merck Kagan Viral and Non Viral Vector Manufacturing Models, Specifications and Application
Table 55. Merck Kagan Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
Table 56. Merck Kagan Recent Developments
Table 57. Oxford Biomedical Plc Company Information, Head Office, Market Area and Industry Position
Table 58. Oxford Biomedical Plc Company Profile and Main Business
Table 59. Oxford Biomedical Plc Viral and Non Viral Vector Manufacturing Models, Specifications and Application
Table 60. Oxford Biomedical Plc Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
Table 61. Oxford Biomedical Plc Recent Developments
Table 62. Sartorius Ag Company Information, Head Office, Market Area and Industry Position
Table 63. Sartorius Ag Company Profile and Main Business
Table 64. Sartorius Ag Viral and Non Viral Vector Manufacturing Models, Specifications and Application
Table 65. Sartorius Ag Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
Table 66. Sartorius Ag Recent Developments
Table 67. Takara Bio Company Information, Head Office, Market Area and Industry Position
Table 68. Takara Bio Company Profile and Main Business
Table 69. Takara Bio Viral and Non Viral Vector Manufacturing Models, Specifications and Application
Table 70. Takara Bio Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
Table 71. Takara Bio Recent Developments
Table 72. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
Table 73. Thermo Fisher Scientific Company Profile and Main Business
Table 74. Thermo Fisher Scientific Viral and Non Viral Vector Manufacturing Models, Specifications and Application
Table 75. Thermo Fisher Scientific Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
Table 76. Thermo Fisher Scientific Recent Developments
Table 77. Wuxi Optec Company Information, Head Office, Market Area and Industry Position
Table 78. Wuxi Optec Company Profile and Main Business
Table 79. Wuxi Optec Viral and Non Viral Vector Manufacturing Models, Specifications and Application
Table 80. Wuxi Optec Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
Table 81. Wuxi Optec Recent Developments
Table 82. Acuities Therapeutic Company Information, Head Office, Market Area and Industry Position
Table 83. Acuities Therapeutic Company Profile and Main Business
Table 84. Acuities Therapeutic Viral and Non Viral Vector Manufacturing Models, Specifications and Application
Table 85. Acuities Therapeutic Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
Table 86. Acuities Therapeutic Recent Developments
Table 87. Evonik Industries Ag Company Information, Head Office, Market Area and Industry Position
Table 88. Evonik Industries Ag Company Profile and Main Business
Table 89. Evonik Industries Ag Viral and Non Viral Vector Manufacturing Models, Specifications and Application
Table 90. Evonik Industries Ag Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
Table 91. Evonik Industries Ag Recent Developments
Table 92. Exiled Company Information, Head Office, Market Area and Industry Position
Table 93. Exiled Company Profile and Main Business
Table 94. Exiled Viral and Non Viral Vector Manufacturing Models, Specifications and Application
Table 95. Exiled Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
Table 96. Exiled Recent Developments
Table 97. Entos Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 98. Entos Pharmaceuticals Company Profile and Main Business
Table 99. Entos Pharmaceuticals Viral and Non Viral Vector Manufacturing Models, Specifications and Application
Table 100. Entos Pharmaceuticals Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
Table 101. Entos Pharmaceuticals Recent Developments
Table 102. Genevant Sciences Gmbh Company Information, Head Office, Market Area and Industry Position
Table 103. Genevant Sciences Gmbh Company Profile and Main Business
Table 104. Genevant Sciences Gmbh Viral and Non Viral Vector Manufacturing Models, Specifications and Application
Table 105. Genevant Sciences Gmbh Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
Table 106. Genevant Sciences Gmbh Recent Developments
Table 107. T&T Scientific Corporation Company Information, Head Office, Market Area and Industry Position
Table 108. T&T Scientific Corporation Company Profile and Main Business
Table 109. T&T Scientific Corporation Viral and Non Viral Vector Manufacturing Models, Specifications and Application
Table 110. T&T Scientific Corporation Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
Table 111. T&T Scientific Corporation Recent Developments
Table 112. Moderna Company Information, Head Office, Market Area and Industry Position
Table 113. Moderna Company Profile and Main Business
Table 114. Moderna Viral and Non Viral Vector Manufacturing Models, Specifications and Application
Table 115. Moderna Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
Table 116. Moderna Recent Developments
Table 117. Curevac Nv Company Information, Head Office, Market Area and Industry Position
Table 118. Curevac Nv Company Profile and Main Business
Table 119. Curevac Nv Viral and Non Viral Vector Manufacturing Models, Specifications and Application
Table 120. Curevac Nv Viral and Non Viral Vector Manufacturing Revenue and Gross Margin, 2018-2023
Table 121. Curevac Nv Recent Developments
List of Figure
Figure 1. Viral and Non Viral Vector Manufacturing Picture
Figure 2. Global Viral and Non Viral Vector Manufacturing Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Viral and Non Viral Vector Manufacturing Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Viral and Non Viral Vector Manufacturing Market Share of Global
Figure 5. Global Viral and Non Viral Vector Manufacturing Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Viral and Non Viral Vector Manufacturing Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Viral and Non Viral Vector Manufacturing Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Viral and Non Viral Vector Manufacturing Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Viral and Non Viral Vector Manufacturing Industry Chain
Figure 10. Viral Vector
Figure 11. Non-viral Vector
Figure 12. By Type, Global Viral and Non Viral Vector Manufacturing Revenue, 2018-2029, US$ Million
Figure 13. By Type, Global Viral and Non Viral Vector Manufacturing Revenue Market Share, 2018-2029
Figure 14. Gene Therapy
Figure 15. Vaccinology
Figure 16. Cell Therapy
Figure 17. Others
Figure 18. By Application, Global Viral and Non Viral Vector Manufacturing Revenue, 2018-2029, US$ Million
Figure 19. By Application, Global Viral and Non Viral Vector Manufacturing Revenue Market Share, 2018-2029
Figure 20. By Region, Global Viral and Non Viral Vector Manufacturing Revenue Market Share, 2018-2029
Figure 21. North America Viral and Non Viral Vector Manufacturing Revenue & Forecasts, 2018-2029, US$ Million
Figure 22. By Country, North America Viral and Non Viral Vector Manufacturing Revenue Market Share, 2018-2023
Figure 23. Europe Viral and Non Viral Vector Manufacturing Revenue & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, Europe Viral and Non Viral Vector Manufacturing Revenue Market Share, 2018-2023
Figure 25. Asia Pacific Viral and Non Viral Vector Manufacturing Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country/Region, Asia Pacific Viral and Non Viral Vector Manufacturing Revenue Market Share, 2018-2023
Figure 27. South America Viral and Non Viral Vector Manufacturing Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, South America Viral and Non Viral Vector Manufacturing Revenue Market Share, 2018-2023
Figure 29. Middle East & Africa Viral and Non Viral Vector Manufacturing Revenue & Forecasts, 2018-2029, US$ Million
Figure 30. U.S. Viral and Non Viral Vector Manufacturing Revenue, 2018-2029, (US$ Million)
Figure 31. By Company, U.S. Viral and Non Viral Vector Manufacturing Market Share, 2018-2023
Figure 32. By Type, U.S. Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
Figure 33. By Application, U.S. Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
Figure 34. Europe Viral and Non Viral Vector Manufacturing Revenue, 2018-2029, (US$ Million)
Figure 35. By Company, Europe Viral and Non Viral Vector Manufacturing Market Share, 2018-2023
Figure 36. By Type, Europe Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
Figure 37. By Application, Europe Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
Figure 38. China Viral and Non Viral Vector Manufacturing Revenue, 2018-2029, (US$ Million)
Figure 39. By Company, China Viral and Non Viral Vector Manufacturing Market Share, 2018-2023
Figure 40. By Type, China Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
Figure 41. By Application, China Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
Figure 42. Japan Viral and Non Viral Vector Manufacturing Revenue, 2018-2029, (US$ Million)
Figure 43. By Company, Japan Viral and Non Viral Vector Manufacturing Market Share, 2018-2023
Figure 44. By Type, Japan Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
Figure 45. By Application, Japan Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
Figure 46. South Korea Viral and Non Viral Vector Manufacturing Revenue, 2018-2029, (US$ Million)
Figure 47. By Company, South Korea Viral and Non Viral Vector Manufacturing Market Share, 2018-2023
Figure 48. By Type, South Korea Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
Figure 49. By Application, South Korea Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
Figure 50. Southeast Asia Viral and Non Viral Vector Manufacturing Revenue, 2018-2029, (US$ Million)
Figure 51. By Company, Southeast Asia Viral and Non Viral Vector Manufacturing Market Share, 2018-2023
Figure 52. By Type, Southeast Asia Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
Figure 53. By Application, Southeast Asia Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
Figure 54. India Viral and Non Viral Vector Manufacturing Revenue, 2018-2029, (US$ Million)
Figure 55. By Company, India Viral and Non Viral Vector Manufacturing Market Share, 2018-2023
Figure 56. By Type, India Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
Figure 57. By Application, India Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
Figure 58. Middle East & Asia Viral and Non Viral Vector Manufacturing Revenue, 2018-2029, (US$ Million)
Figure 59. By Company, Middle East & Asia Viral and Non Viral Vector Manufacturing Market Share, 2018-2023
Figure 60. By Type, Middle East & Asia Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
Figure 61. By Application, Middle East & Asia Viral and Non Viral Vector Manufacturing Revenue Market Share, 2022 VS 2029
Figure 62. Research Methodology
Figure 63. Breakdown of Primary Interviews
Figure 64. Bottom-up Approaches
Figure 65. Top-down Approaches
Reason to Buy